The Other Syndemic: HIV and Obesity

Overview

Journal Obes Surg

Date 2024 Sep 15

PMID 39279002

Authors

Francis M Finucane

Affiliations

Soon will be listed here.

References

Madelain V, Le M, Champenois K, Charpentier C, Landman R, Joly V . Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study. J Antimicrob Chemother. 2017; 72(4):1137-1146. PMC: 5517629. DOI: 10.1093/jac/dkw527. View

Koethe J, Jenkins C, Lau B, Shepherd B, Justice A, Tate J . Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2015; 32(1):50-8. PMC: 4692122. DOI: 10.1089/aid.2015.0147. View

Eckard A, Wu Q, Sattar A, Ansari-Gilani K, Labbato D, Foster T . Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial. Lancet Diabetes Endocrinol. 2024; 12(8):523-534. PMC: 11417641. DOI: 10.1016/S2213-8587(24)00150-5. View

Deeks S, Lewin S, Havlir D . The end of AIDS: HIV infection as a chronic disease. Lancet. 2013; 382(9903):1525-33. PMC: 4058441. DOI: 10.1016/S0140-6736(13)61809-7. View

Hill A, Waters L, Pozniak A . Are new antiretroviral treatments increasing the risks of clinical obesity?. J Virus Erad. 2019; 5(1):41-43. PMC: 6362910. View

McMahon C, Trevaskis J, Carter C, Holsapple K, White K, Das M . Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight. PLoS One. 2020; 15(2):e0229617. PMC: 7048285. DOI: 10.1371/journal.pone.0229617. View

Kaip E, Nguyen N, Cocohoba J . Antiretroviral Therapy Efficacy Post-Bariatric Weight Loss Surgery: A Case Series of Persons Living with Human Immunodeficiency Virus. Obes Surg. 2022; 32(5):1523-1530. PMC: 8986680. DOI: 10.1007/s11695-022-05956-7. View

Batterham R, Bedimo R, Diaz R, Guaraldi G, Lo J, Martinez E . Cardiometabolic health in people with HIV: expert consensus review. J Antimicrob Chemother. 2024; 79(6):1218-1233. PMC: 11144490. DOI: 10.1093/jac/dkae116. View

Akbari K, Som R, Sampson M, Abbas S, Ramus J, Jones G . The Effect of Bariatric Surgery on Patients with HIV Infection: a Literature Review. Obes Surg. 2018; 28(8):2550-2559. DOI: 10.1007/s11695-018-3319-4. View

10.

Venter W, Sokhela S, Simmons B, Moorhouse M, Fairlie L, Mashabane N . Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised,.... Lancet HIV. 2020; 7(10):e666-e676. DOI: 10.1016/S2352-3018(20)30241-1. View

11.

. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Infect Dis. 2024; 24(8):868-895. PMC: 11269650. DOI: 10.1016/S1473-3099(24)00158-0. View

12.

Andrasik M, Broder G, Oseso L, Wallace S, Rentas F, Corey L . Stigma, Implicit Bias, and Long-Lasting Prevention Interventions to End the Domestic HIV/AIDS Epidemic. Am J Public Health. 2019; 110(1):67-68. PMC: 6893342. DOI: 10.2105/AJPH.2019.305454. View